Genes that drive the pathobiology of pediatric pulmonary arterial hypertension
Authors:
- 9 January 2020
- journal article
- review article
- Published by Wiley in Pediatric Pulmonology
- Vol. 56 (3) , 614-620
Abstract
Emerging data from studies of pediatric‐onset pulmonary arterial hypertension (PAH) indicate that the genomics of pediatric PAH is different than that of adults. There is a greater genetic burden in children, with rare genetic factors contributing to at least 35% of pediatric‐onset idiopathic PAH (IPAH) compared with ~11% of adult‐onset IPAH. De novo variants are the most frequent genetic cause of PAH in children, likely contributing to ~15% of all cases. Rare deleterious variants in bone morphogenetic protein receptor 2 (BMPR2) contribute to pediatric‐onset familial PAH and IPAH with similar frequency as adult‐onset. While likely gene‐disrupting (LGD) variants in BMPR2 contribute across the lifespan, damaging missense variants are more frequent in early‐onset PAH. Rare deleterious variants in T‐box 4‐containing protein (TBX4) are more common in pediatric‐compared with adult‐onset PAH, explaining ~8% of pediatric IPAH. PAH associated with congenital heart disease (APAH‐CHD) and other developmental disorders account for a large proportion of pediatric PAH. SRY‐related HMG box transcription factor (SOX17) was recently identified as an APAH‐CHD risk gene, contributing less frequently to IPAH, with a greater prevalence of rare deleterious variants in children compared with adults. The differences in genetic burden and genes underlying pediatric‐ vs adult‐onset PAH indicate that genetic information relevant to pediatric PAH cannot be extrapolated from adult studies. Large cohorts of pediatric‐onset PAH are necessary to identify the unique etiological differences of PAH in children, as well as the natural history and response to therapy.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (UO1 HL125218 and the JPB Foundation (WKC) and RO1 HL134802 (EDA))
This publication has 53 references indexed in Scilit:
- Sox17 is indispensable for acquisition and maintenance of arterial identityNature Communications, 2013
- De novo mutations in epileptic encephalopathiesNature, 2013
- TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertensionJournal of Medical Genetics, 2013
- Multiple Roles and Interactions of Tbx4 and Tbx5 in Development of the Respiratory SystemPLOS Genetics, 2012
- ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experimentsBioinformatics, 2010
- Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2American Journal of Physiology-Heart and Circulatory Physiology, 2010
- Identification of a Recurrent Microdeletion at 17q23.1q23.2 Flanked by Segmental Duplications Associated with Heart Defects and Limb AbnormalitiesThe American Journal of Human Genetics, 2010
- Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethalityProceedings of the National Academy of Sciences, 2009
- Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertensionRespiratory Research, 2009
- A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growthProceedings of the National Academy of Sciences, 2006